1. Zuo, Shiqi, He, Siyuan, Zhu, Zhiqin, Wu, Ziqing, Tang, Yao. 2024. Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation. In Analytical cellular pathology (Amsterdam), 2024, 1373659. doi:10.1155/2024/1373659. https://pubmed.ncbi.nlm.nih.gov/39624160/
2. Urano, Tomohiko, Shiraki, Masataka, Saito, Mitsuru, Ouchi, Yasuyoshi, Inoue, Satoshi. 2013. Polymorphism of SLC25A32, the folate transporter gene, is associated with plasma folate levels and bone fractures in Japanese postmenopausal women. In Geriatrics & gerontology international, 14, 942-6. doi:10.1111/ggi.12201. https://pubmed.ncbi.nlm.nih.gov/24354357/
3. Xue, Zhiwei, Wang, Jiwei, Wang, Zide, Huang, Bin, Wang, Xinyu. 2023. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway. In BMC cancer, 23, 589. doi:10.1186/s12885-023-11097-6. https://pubmed.ncbi.nlm.nih.gov/37365560/
4. Kim, Jimi, Lei, Yunping, Guo, Jin, Wang, Hong-Yan, Finnell, Richard H. 2018. Formate rescues neural tube defects caused by mutations in Slc25a32. In Proceedings of the National Academy of Sciences of the United States of America, 115, 4690-4695. doi:10.1073/pnas.1800138115. https://pubmed.ncbi.nlm.nih.gov/29666258/
5. Wallace-Povirk, Adrianne, O'Connor, Carrie, Dekhne, Aamod S, Hou, Zhanjun, Matherly, Larry H. . Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer. In Molecular cancer therapeutics, 23, 809-822. doi:10.1158/1535-7163.MCT-23-0550. https://pubmed.ncbi.nlm.nih.gov/38377173/
6. Curtabbi, Andrea, Guarás, Adela, Cabrera-Alarcón, José Luis, Medina, Milagros, Enríquez, José Antonio. 2023. Regulation of respiratory complex I assembly by FMN cofactor targeting. In Redox biology, 69, 103001. doi:10.1016/j.redox.2023.103001. https://pubmed.ncbi.nlm.nih.gov/38145589/